Trials / Completed
CompletedNCT02503059
Etanercept Survival in Elderly Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Fundación Pública Andaluza Progreso y Salud · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the 3-year survival of etanercept in patients over 60 years with psoriasis in moderate / severe plaque and the reasons that led to the abandonment. Besides factors that might have had a positive or negative influence on adherence to treatment and analysis of efficacy (PASI 75) and safety will be identified. All variables were collected through retrospective review of medical records of patients dermatology unit are made.
Conditions
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-01-01
- Completion
- 2015-02-01
- First posted
- 2015-07-20
- Last updated
- 2015-07-20
Locations
5 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02503059. Inclusion in this directory is not an endorsement.